Recruiting

Observational Study

Sponsor:

Weill Medical College of Cornell University

Code:

NCT05711446

Conditions

Urinary Tract Infections

Kidney Transplant; Complications

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Double Voiding

Regular Voiding

Study Details

Brief summary:

Urinary tract infections (UTI) are common in kidney transplant recipients and are an important cause of illness and hospital admissions. Past studies have shown that about 1 out of 5 of newly transplanted patients develop UTI within their first 3 months of transplantation. Such UTIs increase the risk for blood stream infection and acute rejection of the kidney, Improvements in urinary voiding techniques may reduce the frequency of UTI. The purpose of this study is to evaluate the benefits of "double voiding" in kidney transplant recipients.

Conditions

Urinary Tract Infections

Kidney Transplant; Complications

Study ID

NCT05711446

Start date

Apr 7, 2023

Status verified date

May, 2026

Completion date

May, 2027

Anticipated

Primary completion date

May, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • All adult kidney transplant recipients who undergo routine follow-up at the New York Presbyterian - Weill Cornell Medicine (NYP-WCM) Transplant Clinic.

Exclusion Criteria:

  • Kidney transplant recipients who are discharged after a transplant with an indwelling catheter (Foley)

Study Design

Enrollment

438 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Prevention

Interventions and Outcome Measures

Arms

experimental: Double Voiding

The participant will be instructed to void twice.

active comparator: Regular Voiding

The participant will be instructed to void normally.

Interventions

Double Voiding

Participant will be instructed to void twice.

Regular Voiding

Participant will void as usual

Primary outcome measure

  • Number of UTI's [ Time Frame: First 3 months of transplantation ]

Central Contacts and Locations

Central contacts

Muthukumar Thangamani, M.D.

212-746-9074mut9002@med.cornell.edu

Ananda Kimm-Drapeau

212-746-6137alk4031@med.cornell.edu

Locations

Weill Cornell Medical College / NY Presbyterian

Recruiting

New York, New York, United States, 10065

Contacts

Thangamani Muthukumar, M.D.

212-746-9074mut9002@med.cornell.edu

Ananda Kimm-Drapeau

212-746-6137alk4031@med.cornell.edu

Principal Investigator:

Thangamani Muthukumar, M.D.

More Information

Sponsor

Weill Medical College of Cornell University

Last update posted

May 22, 2026

Last verified

May, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Weill Medical College of Cornell University on 2026-05-22.